Position in AMGN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,598,211
+$172,206 QoQ
Shares Held
7,175
+4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,133
of 3,140 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL & PAHL PRIVATE WEALTH, LLC holds $18,659,233 across 8 Drug Manufacturers - General names. AMGN ranks #4 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,704 | $4,750,254 | |
| 2 | ABBV |
AbbVie Inc.
|
15,598 | $3,925,080 | |
| 3 | NVS |
Novartis AG
|
23,278 | $3,648,128 | |
| 4 | AMGN |
Amgen Inc
This page
|
7,175 | $2,598,211 | |
| 5 | AZN |
Astrazeneca PLC
|
7,369 | $1,397,309 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,886 | $1,270,351 | |
| 7 | NVO |
Novo Nordisk A S
|
17,814 | $854,003 | |
| 8 | LLY |
ELI LILLY & Co
|
180 | $215,897 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,598,211 | 7,175 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $2,426,005 | 6,895 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,190,031 | 6,691 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,878,041 | 6,655 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,846,415 | 6,613 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,968,061 | 6,317 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,532,302 | 5,879 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,676,458 | 5,203 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,595,682 | 5,107 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,448,326 | 5,094 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,392,288 | 4,834 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,347,831 | 5,015 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,000,422 | 4,506 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,006,405 | 4,163 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,017,730 | 3,875 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $818,202 | 3,630 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $797,780 | 3,279 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $716,270 | 2,962 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $561,525 | 2,496 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $494,836 | 2,327 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $504,806 | 2,071 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $422,728 | 1,699 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $341,891 | 1,487 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||